Thomas Frisell

机构：Karolinska Institutet · ORCID：0000-0002-5735-9626

发表论文 231 篇 · 总被引 7608 次 · h-index 46

代表论文

Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register (2025 · European Journal of Epidemiology · 被引 128)
COMBAT ‐ MS : A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab (2024 · Annals of Neurology · 被引 28)
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis (2023 · RMD Open · 被引 21)
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study (2023 · Seminars in Arthritis and Rheumatism · 被引 20)
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies (2023 · Annals of the Rheumatic Diseases · 被引 19)
Real‐World Healthcare Cost Savings and Reduced Relapse Rate with Off‐Label Rituximab versus Disease‐Modifying Treatments Approved for Relapsing–Remitting Multiple Sclerosis: A Nationwide Cost‐Effectiveness Study (2024 · Annals of Neurology · 被引 18)